chrX-38403673-A-T
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000531.6(OTC):c.596A>T(p.Asn199Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N199D) has been classified as Pathogenic.
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000531.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTC | NM_000531.6 | MANE Select | c.596A>T | p.Asn199Ile | missense | Exon 6 of 10 | NP_000522.3 | ||
| OTC | NM_001407092.1 | c.596A>T | p.Asn199Ile | missense | Exon 8 of 12 | NP_001394021.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTC | ENST00000039007.5 | TSL:1 MANE Select | c.596A>T | p.Asn199Ile | missense | Exon 6 of 10 | ENSP00000039007.4 | ||
| ENSG00000250349 | ENST00000465127.1 | TSL:5 | c.172-262448A>T | intron | N/A | ENSP00000417050.1 | |||
| OTC | ENST00000713758.1 | c.596A>T | p.Asn199Ile | missense | Exon 8 of 12 | ENSP00000519059.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
OTC-related disorder Pathogenic:1
The OTC c.596A>T variant is predicted to result in the amino acid substitution p.Asn199Ile. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Different amino acid substitutions impacting the p.Asn199 amino acid have been reported in patients with OTC deficiency (e.g., p.Asn199His in Ali et al. 2018. PubMed ID: 30175132; p.Asn199Asp in Yamaguchi et al. 2006. PubMed ID: 16786505; p.Asn199Ser in Tuchman et al. 2002. PubMed ID: 11793468). Numerous other amino acid substitutions surrounding this location have also been reported in patients with OTC deficiency (Human Gene Mutation Database, https://www.hgmd.cf.ac.uk/). Taken together, the c.596A>T (p.Asn199Ile) variant is interpreted as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at